There’s a simple way to double or even triple your company’s stock price overnight: announce positive results from a clinical trial involving a drug to treat the fatty liver disease known as NASH.
No need to offer convincing proof the drug works. Investors, besotted by the blockbuster commercial opportunity a NASH drug might deliver, seem willing to believe just about anything.
About the Author Reprints
